Published in Crit Care Med on June 01, 2001
The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction. Clin Res Cardiol (2007) 0.80
Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Can J Cardiol (2006) 0.75
Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score. Int J Angiol (2015) 0.75
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med (1996) 6.05
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
The prognostic value of serum troponin T in unstable angina. N Engl J Med (1992) 5.04
Expectation biases in observational evaluation of therapeutic change. J Consult Clin Psychol (1974) 3.74
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 3.17
Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 2.73
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation (2001) 2.36
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27
U-21,963, a new antibiotic. I. Discovery and biological activity. Appl Microbiol (1966) 2.16
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Troponin elevation in coronary vs. non-coronary disease. Eur Heart J (2010) 1.93
Myocardial ischemia in generalized coronary artery-left ventricular microfistulae. Int J Cardiol (1998) 1.88
Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol (2007) 1.77
Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation (2000) 1.76
Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem (1998) 1.75
Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation (2000) 1.67
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation (1995) 1.66
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Effectiveness of end-tidal carbon dioxide tension for monitoring thrombolytic therapy in acute pulmonary embolism. Crit Care Med (2000) 1.61
Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation (1995) 1.61
Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol (1997) 1.60
Inhibition of ventricular stimulation in patients with dual chamber pacemakers and prolonged AV conduction. Pacing Clin Electrophysiol (1999) 1.59
Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem (1997) 1.58
Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol (2006) 1.58
Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J (2000) 1.56
Cardiomyopathies: from genetics to the prospect of treatment. Lancet (2001) 1.54
Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley. Clin Res Cardiol (2007) 1.54
Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovasc Res (2000) 1.50
A unique pitfall in percutaneous coronary angioplasty of in-stent restenosis: guidewire passage out of the stent. Catheter Cardiovasc Interv (2001) 1.49
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
Tobacco and alcohol and the risk of head and neck cancer. Clin Investig (1992) 1.49
Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning. Cardiovasc Res (2001) 1.45
TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene (1998) 1.45
Atrial sensing and AV synchrony in single lead VDD pacemakers: a prospective comparison to DDD devices with bipolar atrial leads. J Cardiovasc Electrophysiol (1999) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
[Evaluation of a training system for middle ear surgery with optoelectric detection]. HNO (2009) 1.40
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation (1994) 1.31
Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene (2006) 1.29
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta (1996) 1.29
"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28
Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis (2011) 1.28
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther (2007) 1.23
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res (1987) 1.23
Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol (1995) 1.21
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart (2002) 1.19
Taxonomy by carbon replication. II. Examination of eight additional cultures of Streptomyces hygroscopicus. Appl Microbiol (1968) 1.18
The suppurative abscess of an endometriosic ovarian cyst due to Salmonella brandenburg. Infection (1982) 1.18
Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem (2000) 1.17
Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. Chest (2000) 1.17
microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther (2010) 1.16
Activation of beta-adrenergic receptor kinase during myocardial ischemia. Circ Res (1996) 1.15
Lomofungin, a new antibiotic produced by Streptomyces lomondensis sp. n. Appl Microbiol (1969) 1.13
New Dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Physiol Genomics (2001) 1.10
Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol (2006) 1.09
Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer (2011) 1.09
Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin Res Cardiol (2010) 1.08
Streptomyces steffisburgensis sp.n. J Bacteriol (1967) 1.07
Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications. Ultraschall Med (2006) 1.06
Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis (2000) 1.06
Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Gene Ther (2011) 1.05
Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart (1996) 1.05
Zervamicins I and II, polypeptide antibiotics produced by emericellopsis salmosynnemata. J Antibiot (Tokyo) (1974) 1.05
An optimized AV delay algorithm for patients with intermittent atrioventricular conduction. Pacing Clin Electrophysiol (1998) 1.05
Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Ther (2010) 1.05
[Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr (2005) 1.05
Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J (1991) 1.04
Navigated control in functional endoscopic sinus surgery. Int J Med Robot (2005) 1.04
Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant (2006) 1.04
Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.03
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors. J Clin Oncol (1996) 1.03
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation (1998) 1.01
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med (2011) 1.01
Time course of restenosis during the first year after emergency coronary stenting. Circulation (1993) 1.01
Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. J Am Coll Cardiol (2001) 1.01
Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol (2012) 1.00
Transgenic animal models: new avenues in cardiovascular physiology. J Mol Med (Berl) (1997) 1.00
Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. Am J Cardiol (1984) 1.00
CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism. J Antibiot (Tokyo) (1978) 1.00
Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest (2007) 0.99
Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of life. Clin Biochem (2008) 0.99
Antiphospholipid antibodies in children without and in adults with and without thrombophilia. Thromb Res (2000) 0.99
Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol (2001) 0.99